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Abstract. The applicability of micellar electrokinetic capillary chromatography (MEKC) for the separation 
of benzodiazepine (BZD) derivates with different structural characteristics has been studied. Efforts were 
first focused on the optimization of the analytical conditions, on the effects of buffer concentration, sur-
factant concentration and buffer pH on the separation. To manipulate selectivity of the separation β-
cyclodextrin (CD) was added to the buffer solution, and urea was used to improve the solubility of the CD 
in water. The CD-modified MEKC separation of the eight BZDs was achieved within 15 minutes using 25 
mmol dm−3 natrium tetraborate-50 mmol dm−3 sodium dodecyl sulphate-15 mmol dm−3 β-CD-2 mol dm−3 
urea (pH 9.3) as the running buffer. The proposed separation method was evaluated on the basis of preci-
sion, linearity and limit of detection. (doi: 10.5562/cca1763) 
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INTRODUCTION 
Benzodiazepines (BZDs) are the most widely used psy-
chotropic drugs, especially for their anxiolityc effects, 
but some compounds are also used as sedatives, hypnot-
ics, anticonvulsants, muscular relaxants or general anes-
thetics.1 To emphasize even more their importance we 
can mention the great number of officinal BZD deri-
vates in the modern pharmacopoeias: 15 derivates in the 
6th edition of the European Pharmacopoeia – EPh6,2 14 
derivates in the British Pharmacopoeia 2009 – 
BPh20093 and 17 derivates and other 6 pharmaceutical 
formulations containing BZDs in the United States 
Pharmacopoeia 32 – USP32.4 
The great therapeutic importance of these com-
pounds is closely linked with their analytical aspects, so 
development of new methods of analysis is a permanent 
challenge and also a necessity. 
Since its introduction, capillary electrophoresis 
(CE), nowadays an officinal method in EPh6,2 has 
shown great potential in the analysis of pharmaceutical 
compounds. Due to its speed of analysis, high separa-
tion efficiency and low solvent and sample consump-
tion, CE is being regarded as an alternative or a com-
plementary separation technique to the more frequently 
used high-performance liquid chromatography (HPLC).5 
BZDs are mostly neutral from electrophoretic 
point of view and have almost similar hydrophobicities,6 
hence a good separation by the conventional capillary 
zone electrophoresis (CZE), method based on the differ-
ences between the own electrophoretic mobilities of the 
analytes, cannot be expected. This problem can be 
solved by micellar electrokinetic capillary chromatogra-
phy (MEKC), method that extends the applicability of 
CE to neutral molecules. 
This method is based on the addition of a surfac-
tant (sodium dodecyl sulphate - SDS) to the buffer solu-
tion above its critical micellar concentration (CMC). 
When the BZD sample is injected, it partitions itself 
between the buffer and micelle, therefore, the separation 
occurs due to the differences in the partition coefficient 
between the two phases, in a chromatography-like 
mode.3,7 
The anionic SDS micelles are electrostatically at-
tracted towards the anode, but because of the electroos-
motic flow (EOF) which is usually stronger than the 
electrophoretic migration, the anionic micelles will 
slowly migrate towards the cathode, in the direction of 
the detector.7,8 
Our previous studies9,10 showed that in order to 
improve the separation of BZD we have to use additives 
(organic solvents – methanol, acetonitrile) to modify the 
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aqueous phase consequently manipulating selectivity. In 
general, addition of organic solvents reduces the electro-
osmotic velocity and, hence, expands the migration time 
window, improving selectivity of the separation.9,11,12 
Another alternative would be the addition of cyc-
lodextrines (CDs) to the buffer solution. CDs are cyclic 
oligosaccharides having an external hydrophilic surface 
and a hydrophobic cavity, in which they can include 
other compounds, which fit in their cavity by hydro-
phobic interaction. The most common and commercial-
ly available are the α-, β-, and γ-CDs, formed by α-1,4-
linked glucopyranose subunits, have the shape of a 
truncated cone and contain six, seven respectively eight 
subunits in their structure (Figure 1).13,14 
In the present work 8 of the most frequently used 
BZD derivates were analyzed by means of MEKC. Our 
aim was not only the separation of the 8 BZD derivates 
but also the optimization of analytical conditions (ef-
forts were focused on the study of the effect of buffer 
concentration, modifier concentration, additive concen-
tration, buffer pH on the separation). 
 
EXPERIMENTAL 
We chose eight of the most frequently used BZD deri-
vates, each having different structural characteristics:1,6 
alprazolam, bromazepam, medazepam, nitrazepam (La-
bormed, Bucureşti, Romania), chlorazepate dipotassi-
um, chlordiazepoxide, diazepam, oxazepam (Terapia, 
Cluj-Napoca, Romania) (Figure 2). 
We used substances and reagents of analytical 
grade: natrium tetraborate, sodium dodecyl sulphate, 
urea (Merck, Darmstadt, Germany), sodium hydroxide 
0,1N (Fluka, Buchs, Switzerland), β-cyclodextrin (CD) 
(Cyclolab, Budapest, Hungary). 
The CE instrument was an Agilent CE 6100 sys-
tem. Separations were performed on polyimide-coated 
fused silica capillaries of 64.5 cm (effective length 56 
cm) X 50 μm (Agilent, Waldbronn, Germany). The 
samples were introduced by hydrodynamic injection (50 
mbar for 5 seconds) at the anodic end of the capillary. 
The applied voltage was + 25 kV. The generated current 
was kept below 200 μA. The temperature of the capil-
lary holder was kept at 25 °C. The detection was carried 
out by on-column photometric measurement at 214 nm. 
The diode array detection (DAD) system made it possi-
ble to record the UV spectra at different points of the 
electropherogram. The electropherograms were record-
ed and processed by Chemstation software (Agilent, 
Waldbronn, Germany). 
The sample solutions were prepared by dissolving 
the solid salts in methanol, and then by diluting it with 
water (1:1). Chlorazepate being used, as a potassium 
salt is not soluble in methanol, so in this case the solu-
tion was prepared by solubilization in water and dilution 
with methanol. The concentration of the stock solutions 
was 100 mg/l. The capillaries were preconditioned with 
the buffer electrolyte for 5 minutes. After and the be-
ginning of each daily work the capillaries were flushed 
with sodium hydroxide 0.1 mol dm−3 (5 minutes) and 
distilled water (5 minutes) to remove all the components 
which may stick to the capillary walls. All the samples 
and buffers were filtered through a 0.45 μm syringe 
filter and stored in a refrigerator at + 4 °C. 
 
RESULTS AND DISCUSSION 
As we anticipated CZE was not suited for the separation 
of neutral substances like BZDs. All BZDs migrated very 
close the EOF, with the exception of chlorazepate dipo-
tassium, which was used as a salt, so is a ionic analyte, 
consequently has its own electrophoretic mobility, and 
 
Figure 1. Chemical structure and schematic model of cyclo-
dextrins: α-CD (n–0), β-CD (n–1) and γ-CD (n–2). 
Figure 2. Chemical structure of the studied BZDs. 
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can be separated from the other BZDs by CZE using a 
buffer solution containing 25 mM sodium tetraborate. 
The higher the concentrations of electrolyte (bo-
rate ions), the later the migration times for each BZD, 
because the EOF decreases with an increase in ionic 
strength. In this work, the borate concentration was set 
at 25 mmol dm−3. 
The migration times of the studied BZDs in-
creased with increasing SDS concentration, due to the 
solubilization of the solute in the micellar phase. In this 
work, the SDS concentration was set at 50 mmol dm−3. 
Higher concentrations of surfactants (>100 mmol dm−3) 
resulted in relatively high viscosities and high currents, 
and should be avoided. 
To decide the optimum pH value, we examined 
the value between 3.6 and 9.8, and found that the migra-
tion times had the tendency to increase at lower pH, but 
had no marked effect over the pH 8 to 10.9,10 
However using only SDS, the retention factors of 
BZDs are high, due to their high and comparable hydro-
phobicity. Therefore, these drugs migrate close to the 
SDS micelle and resolution is limited. 
This problem was resolved by adding a neutral CD 
to the micellar solution. CDs are electrically neutral and 
have no electrophoretic mobility, consequently will not 
be incorporated in the micelle because of the hydrophil-
ic nature of the outside. The migration velocity and 
hence the migration times of BZDs depends on the 
partitioning of the solute between the CD and the mi-
celle (Figure 3).8,15,16 
This technique is limited to solutes, which can fit 
into the CD cavity. The ratio of the solute incorporated 
into the micelle depends on its hydrophobicity but the 
inclusion complex formation of the solute with CD 
depends on the concordance of the solute molecular size 
with the CD cavity diameter.13,15 
Using a molecular modulation program, Chem3D 
(CambridgeSoft), we followed the molecular complexa-
tion of BZDs with CDs. Having a rigid structure with a 
benzene ring condesated to a diazepinic one the comple-
xation process for BZDs is difficult and far from perfect. 
BZD can’t fit in the cavity of α-CD, but fit even if just 
partially in cavities of β- respectively γ-CD (Figure 4). 
Among various CDs, γ-CD in general is consi-
dered to be most effective in MEKC separations,14,15 but 
in this work we chose β-CD arguably the most frequent-
ly used CD for the complexation of chemical com-
pounds of pharmaceutical interest. 
A decrease in the EOF and a shortening of the mi-
gration time of the BZDs with increasing CD concentra-
tion was observed (Figure 5). High concentration of CDs 
may lead to an increase of the solubilization in the CD ca-
Figure 3. Schematic of the separation principle of CD-MEKC.
 
Figure 4. Complexation of Diazepam with β-CD. 
Figure 5. Influence of CD concentration on the separation of
BZDs (separation conditions: capillary 50 cm × 50 μm I.D,
buffer electrolyte 25 mM borate + 50 mM SDS, pH 9.3, ap-
plied voltage + 25 kV, detection UV 214 nm, concentration of
each BZD 10 μg/ml). 
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vity, and migration of the solutes with the EOF.15 In this 
work, the CD concentration was set at 15 mmol dm−3. 
The solubility of β-CD in water is relatively low. 
Addition of a high concentration of urea (2 mol dm−3) 
was used to increase solubility. Urea slightly reduces 
the electrosmotic velocity and considerably reduces the 
migration velocity of the micelle, improving the separa-
tion of highly hydrophobic compounds such as BZDs. 
We obtained the best electropherograms using a 
buffer solution containing 25 mmol dm−3 sodium tetrabo-
rate, 50 mmol dm−3 SDS, 15 mmol dm−3 β-CD and 2 mol 
dm−3 urea (pH 9.3) (Figure 6), when we managed the 
separation of the 8 BZDs in less then 15 minutes. The 
separation occurred in the following order: bromazepam, 
nitrazepam, chlordiazepoxide, alprazolam, oxazepam, 
diazepam, medazepam and chlorazepate dipotassium. 
The elution order should agree with the tendency 
of the BZDs to form inclusion complexes with the CD 
in the presence of SDS. A solute having a shorter migra-
tion time is more strongly included in the CD cavity 
than a solute having a longer migration time. 
It is well established that oxazepam and chlo-
razepate dipotassium are optically active, having a chir-
al center in the C3 position.
1 However pure enantiomers 
are difficult to isolate, because they are quickly race-
mized in aqueous medium. It is interesting that peak 
splitting didn’t occurred when we used β-CD as buffer 
additive, but separation of the two enantiomers can be 
solved using hydroxypropyl-β-CD (HP-β-CD) as addi-
tive, because of the different affinities displayed by the 
selector molecules towards the two enantiomers.17 
The analytical performance of the optimized me-
thod was evaluated on the basis of precision (by calcu-
lating regional standard deviation- RSD for the migra-
tion time and peak area), linearity and limit of detection 
(LOD). 
The calculation of LODs was based on a signal-to-
noise ratio of 3. Very similar migration time and peak 
area were obtained for ten repeated measurements of the 
eight compounds which proves a good precision of the 
method (Table 1). 
The individual linear regression equations for each 
BZD were calculated according to six concentrations 
and three replicates per concentrations. The correlation 
coefficient ranged between 0.983 (alprazolam) and 
0.993 (diazepam). The analytical signal shows a linear 
dependence on the analyte concentration, in the concen-
tration domain between 5–100 μg/ml. 
 
Figure 6. Electropherogram of a mixture of BZDs using a a buffer solution containing 25 mM natrium tetrabotate, 50 mM SDS,
15mM β-CD and 2 M urea (pH – 9.3) (separation conditions: capillary 50 cm × 50 μm I.D, applied voltage + 25 kV, detection UV
214 nm, concentration of each BZD 10 μg/ml). 
Table 1. Analytical parameters of the separation of BZD derivates 
 Benzodiazepines 
Migration time / 
min 
Mobility / 
cm2  kV−1 min−1 
LOD / 
μg ml−1 
RSD / % 
migration time 
RSD / % 
peak area 
 Bromazepam 10.50 −10.35 1.42 0.21 0.54 
 Nitrazepam 11.15 −11.11 0.61 0.20 0.42 
 Chlordiazepoxide 11.85 −11.87 0.63 0.21 0.48 
 Alprazolam 12.45 −12.46 0.98 0.18 0.58 
 Oxazepam 12.90 −12.78 0.92 0.15 0.56 
 Diazepam 13.60 −13.36 0.58 0.28 0.88 
 Medazepam 14.40 −14.03 1.38 0.22 0.98 
 Chlorazepate 15.30 −14.62 1.51 0.37 1.36 
signal / noise ratio = 3. 
c = 100 μg/ml, n = 10. 
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CONCLUSIONS 
In summary, we studied in detail the CE conditions for 
the analysis of BZD derivates. 
MEKC can separate both ionic and neutral sub-
stances while CZE separates only ionic substances. The 
separation principle of MEKC is based on the partition 
of the solute between the micelle and water, while in 
CZE is based on the differential electrophoretic mobility 
of the analytes. 
The use of additives to modify the aqueous phase 
is very effective in manipulating selectivity of the sepa-
ration. The addition of CD reduces the distribution coef-
ficient and enables the separation of highly hydrophobic 
analytes, which otherwise would be almost completely 
incorporated into the micelle. 
The selectivity and resolution of the method can 
be also controlled and manipulated by varying the buf-
fer concentration, surfactant concentration, buffer pH or 
CD concentration. 
The optimal running buffer was 25 mmol dm−3 na-
trium tetraborate-50 mmol dm−3 sodium dodecyl sul-
phate-15 mmol dm−3 β-CD-2 mol dm−3 urea (pH 9.3), 
the running time was around 15 minutes and the elution 
order was: bromazepam, nitrazepam, chlordiazepoxide, 
alprazolam, oxazepam, diazepam, medazepam, chlora-
zepate dipotassium. 
CD-MEKC proved an efficient tool for the separa-
tion of the studied BZD derivates and probably for other 
substances with similar chemical structures. The me-
thods can find practical application in the determination 
of BZD derivates from biological fluids. 
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